Loading...

Parya Saberi, PharmD

Title(s)Associate Professor, Medicine
SchoolSchool of Medicine
Phone415-502-1000 ext. 17171
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    University of California, San FranciscoM.A.S. in Clinical Research2011 Graduate Division (Advance Training in Clinical Research)
    University of California, San Francisco Residency

    Collapse Overview 
    Collapse Overview
    Parya Saberi, PharmD, MAS,AAHIVP is an Associate Professor at the Center for AIDS Prevention Studies (CAPS) in the Department of Medicine at the University of California, San Francisco. Dr. Saberi is funded by the National Institute of Mental Health (NIMH) through an R34 award, the National Institute of Nursing Research (NINR) through an R01 award, and the California HIV Research Program (CHRP) for Health Disparities. Her research includes assessing technology-based strategies such as mobile applications, video-conferencing tools, and text messaging to improve ART adherence and engagement in HIV care among youth living with HIV. She is also examining novel adherence assessment methods and an HIV pre-exposure prophylaxis (PrEP) tool for healthcare providers who are prescribing PrEP. Her other research involvement includes developing a technology-based tool for HIV prevention and treatment for the San Francisco Bay Area House Ball Community and Gay Families (PI: Dr. Emily Arnold). She is currently an expert consultant at the National Clinicians' Consultation Center's HIV Warmline, PEPline, and PrEPline (nccc.ucsf.edu).

    Collapse Research 
    Collapse Research Activities and Funding
    Improving the HIV PrEP Cascade using an Intervention for Healthcare Providers
    NIH/NINR R01NR017573Sep 20, 2017 - Jun 30, 2021
    Role: Principal Investigator
    A Mobile Health Application for Engagement in Care among Youth Living with HIV
    NIH/NIMH R34MH114604Aug 15, 2017 - Jun 30, 2020
    Role: Principal Investigator
    Rx Pix: A Novel Way to Assess Antiretroviral Adherence with Pharmacy Refill Dates
    NIH/NIMH R21MH108414Feb 19, 2016 - Dec 31, 2017
    Role: Principal Investigator
    Technology-based adaptive treatment strategies for antiretroviral adherence
    NIH/NIMH K23MH097649Jun 15, 2012 - Apr 30, 2017
    Role: Principal Investigator
    Quality of Sleep in HIV-Infection: associations with treatment and adherence
    NIH/NIMH F32MH086323Jul 1, 2009 - Jun 30, 2012
    Role: Principal Investigator

    Collapse ORNG Applications 
    Collapse Clinical Trials
    Collapse Global Health
    Collapse Websites

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Dubé K, Eskaf S, Evans D, Sauceda J, Saberi P, Brown B, Averitt D, Martel K, Meija M, Campbell D, Barr L, Kanazawa J, Perry K, Patel H, Luter S, Poteat T, Auerbach JD, Wohl DA. The Dose Response: Perceptions of People Living with HIV in the United States on Alternatives to Oral Daily Antiretroviral Therapy. AIDS Res Hum Retroviruses. 2019 Dec 04. PMID: 31608651.
      View in: PubMed
    2. Wootton AR, McCuistian C, Legnitto Packard DA, Gruber VA, Saberi P. Overcoming Technological Challenges: Lessons Learned from a Telehealth Counseling Study. Telemed J E Health. 2019 Dec 03. PMID: 31800368.
      View in: PubMed
    3. Saberi P, Chakravarty D, Ming K, Legnitto D, Gandhi M, Johnson MO, Neilands TB. Moving Antiretroviral Adherence Assessments to the Modern Era: Correlations Among Three Novel Measures of Adherence. AIDS Behav. 2019 Nov 22. PMID: 31758349.
      View in: PubMed
    4. Wootton AR, Legnitto DA, Gruber VA, Dawson-Rose C, Neilands TB, Johnson MO, Saberi P. Telehealth and texting intervention to improve HIV care engagement, mental health and substance use outcomes in youth living with HIV: a pilot feasibility and acceptability study protocol. BMJ Open. 2019 Jul 16; 9(7):e028522. PMID: 31315868.
      View in: PubMed
    5. Reeder C, Neilands TB, Palar K, Saberi P. Food Insecurity and Unmet Needs Among Youth and Young Adults Living With HIV in the San Francisco Bay Area. J Adolesc Health. 2019 Aug; 65(2):262-266. PMID: 31196781.
      View in: PubMed
    6. Saberi P, Dawson Rose C, Wootton AR, Ming K, Legnitto D, Jeske M, Pollack LM, Johnson MO, Gruber VA, Neilands TB. Use of technology for delivery of mental health and substance use services to youth living with HIV: a mixed-methods perspective. AIDS Care. 2019 May 28; 1-9. PMID: 31132864.
      View in: PubMed
    7. Erguera XA, Johnson MO, Neilands TB, Ruel T, Berrean B, Thomas S, Saberi P. WYZ: a pilot study protocol for designing and developing a mobile health application for engagement in HIV care and medication adherence in youth and young adults living with HIV. BMJ Open. 2019 May 05; 9(5):e030473. PMID: 31061063.
      View in: PubMed
    8. Saberi P, Ming K, Legnitto D, Neilands TB, Gandhi M, Johnson MO. Feasibility and acceptability of novel methods to estimate antiretroviral adherence: A longitudinal study. PLoS One. 2019; 14(1):e0210791. PMID: 30645641.
      View in: PubMed
    9. Saberi P, Neilands TB, Lally MA, Hosek SG, Hightow-Weidman L. The Association between Use of Online Social Networks to Find Sex Partners and Sexually Transmitted Infection Diagnosis among Young Men Who Have Sex with Men and Transgender Women Living with HIV. J Int Assoc Provid AIDS Care. 2019 Jan-Dec; 18:2325958219867324. PMID: 31389285.
      View in: PubMed
    10. Olea A, Grochowski J, Luetkemeyer AF, Robb V, Saberi P. Role of a clinical pharmacist as part of a multidisciplinary care team in the treatment of HCV in patients living with HIV/HCV coinfection. Integr Pharm Res Pract. 2018; 7:105-111. PMID: 30214893.
      View in: PubMed
    11. Saberi P, Ming K, Legnitto D, Neilands TB, Gandhi M, Johnson MO. Novel methods to estimate antiretroviral adherence: protocol for a longitudinal study. Patient Prefer Adherence. 2018; 12:1033-1042. PMID: 29950816.
      View in: PubMed
    12. Saberi P, Ming K, Dawson-Rose C. What does it mean to be youth-friendly? Results from qualitative interviews with health care providers and clinic staff serving youth and young adults living with HIV. Adolesc Health Med Ther. 2018; 9:65-75. PMID: 29731672.
      View in: PubMed
    13. Sauceda JA, Neilands TB, Johnson MO, Saberi P. An update on the Barriers to Adherence and a Definition of Self-Report Non-adherence Given Advancements in Antiretroviral Therapy (ART). AIDS Behav. 2018 03; 22(3):939-947. PMID: 28352983.
      View in: PubMed
    14. Saberi P, Berrean B, Thomas S, Gandhi M, Scott H. A Simple Pre-Exposure Prophylaxis (PrEP) Optimization Intervention for Health Care Providers Prescribing PrEP: Pilot Study. JMIR Form Res. 2018 Jan-Jun; 2(1). PMID: 30637375.
      View in: PubMed
    15. Koss CA, Hosek SG, Bacchetti P, Anderson PL, Liu AY, Horng H, Benet LZ, Kuncze K, Louie A, Saberi P, Wilson CM, Gandhi M. Comparison of Measures of Adherence to Human Immunodeficiency Virus Preexposure Prophylaxis Among Adolescent and Young Men Who Have Sex With Men in the United States. Clin Infect Dis. 2018 01 06; 66(2):213-219. PMID: 29020194.
      View in: PubMed
    16. Saberi P, Neilands TB, Ming K, Johnson MO, Kuncze K, Koss CA, Gandhi M. Strong Correlation Between Concentrations of Antiretrovirals in Home-Collected and Study-Collected Hair Samples: Implications for Adherence Monitoring. J Acquir Immune Defic Syndr. 2017 12 01; 76(4):e101-e103. PMID: 28657913.
      View in: PubMed
    17. van den Berg JJ, Neilands TB, Johnson MO, Chen B, Saberi P. Using Path Analysis to Evaluate the Healthcare Empowerment Model Among Persons Living with HIV for Antiretroviral Therapy Adherence. AIDS Patient Care STDS. 2016 11; 30(11):497-505. PMID: 27849372.
      View in: PubMed
    18. Sauceda JA, Johnson MO, Saberi P. Nonadherence as 4-day Antiretroviral Therapy Interruptions: Do Depression and Race/Ethnicity Matter as Much in the Modern Antiretroviral Therapy Era? AIDS Behav. 2016 11; 20(11):2624-2628. PMID: 26767532.
      View in: PubMed
    19. Saberi P, Siedle-Khan R, Sheon N, Lightfoot M. The Use of Mobile Health Applications Among Youth and Young Adults Living with HIV: Focus Group Findings. AIDS Patient Care STDS. 2016 06; 30(6):254-60. PMID: 27214751.
      View in: PubMed
    20. Lippman SA, Shade SB, Sumitani J, DeKadt J, Gilvydis JM, Ratlhagana MJ, Grignon J, Tumbo J, Gilmore H, Agnew E, Saberi P, Barnhart S, Steward WT. Evaluation of short message service and peer navigation to improve engagement in HIV care in South Africa: study protocol for a three-arm cluster randomized controlled trial. Trials. 2016 Feb 06; 17:68. PMID: 26852237.
      View in: PubMed
    21. Gilvydis JM, Steward WT, Saberi P, Tumbo J, Sumitani J, Barnhart S, Lippman SA. Need for improvements in clinical practice to retain patients in pre-antiretroviral therapy care: Data from rural clinics in North West Province, South Africa. AIDS Care. 2015; 27(10):1275-8. PMID: 26278130.
      View in: PubMed
    22. Saberi P, Johnson MO. Correlation of Internet Use for Health Care Engagement Purposes and HIV Clinical Outcomes Among HIV-Positive Individuals Using Online Social Media. J Health Commun. 2015; 20(9):1026-32. PMID: 26120890.
      View in: PubMed
    23. Saberi P, Catz SL, Leyden WA, Stewart C, Ralston JD, Horberg MA, Grothaus L, Silverberg MJ. Antiretroviral Therapy Adherence and Use of an Electronic Shared Medical Record Among People Living with HIV. AIDS Behav. 2015 Jun; 19 Suppl 2:177-85. PMID: 25572829.
      View in: PubMed
    24. Saberi P, Neilands TB, Vittinghoff E, Johnson MO, Chesney M, Cohn SE. Barriers to antiretroviral therapy adherence and plasma HIV RNA suppression among AIDS clinical trials group study participants. AIDS Patient Care STDS. 2015 Mar; 29(3):111-6. PMID: 25615029.
      View in: PubMed
    25. Saberi P, Mayer K, Vittinghoff E, Naar-King S. Correlation between use of antiretroviral adherence devices by HIV-infected youth and plasma HIV RNA and self-reported adherence. AIDS Behav. 2015 Jan; 19(1):93-103. PMID: 24879628.
      View in: PubMed
    26. Saberi P, Johnson MO. Moving toward a novel and comprehensive behavioral composite of engagement in HIV care. AIDS Care. 2015; 27(5):660-4. PMID: 25471139.
      View in: PubMed
    27. Saberi P, Neilands TB, Johnson MO. Association between dog guardianship and HIV clinical outcomes. J Int Assoc Provid AIDS Care. 2014 Jul-Aug; 13(4):300-4. PMID: 25513022.
      View in: PubMed
    28. Parya Saberi, Torsten B. Neilands, Mallory O. Johnson. Association between Dog Guardianship and HIV Clinical Outcomes. Journal of the International Association of Providers of AIDS Care (JIAPAC). 2014 Jul 1; 13(4):300-304.
      View in: Publisher Site
    29. Yuan P, Bare MG, Johnson MO, Saberi P. Using online social media for recruitment of human immunodeficiency virus-positive participants: a cross-sectional survey. J Med Internet Res. 2014 May 01; 16(5):e117. PMID: 24784982.
      View in: PubMed
    30. Sevelius JM, Saberi P, Johnson MO. Correlates of antiretroviral adherence and viral load among transgender women living with HIV. AIDS Care. 2014; 26(8):976-82. PMID: 24646419.
      View in: PubMed
    31. Cocohoba J, Dong BJ, Johnson MO, Saberi P. Reporting of critical information in studies of pharmacists in HIV care. Int J Pharm Pract. 2014 Dec; 22(6):375-85. PMID: 24467531.
      View in: PubMed
    32. Saberi P, Yuan P, John M, Sheon N, Johnson MO. A pilot study to engage and counsel HIV-positive African American youth via telehealth technology. AIDS Patient Care STDS. 2013 Sep; 27(9):529-32. PMID: 23991691.
      View in: PubMed
    33. Saberi P, Comfort M, Sheon N, Johnson MO. Qualitative study of the quality of sleep in marginalized individuals living with HIV. Patient Prefer Adherence. 2013; 7:499-507. PMID: 23807839.
      View in: PubMed
    34. Saberi P, Phengrasamy T, Nguyen DP. Inhaled corticosteroid use in HIV-positive individuals taking protease inhibitors: a review of pharmacokinetics, case reports and clinical management. HIV Med. 2013 Oct; 14(9):519-29. PMID: 23590676.
      View in: PubMed
    35. Saberi P, Gamarel KE, Neilands TB, Comfort M, Sheon N, Darbes LA, Johnson MO. Ambiguity, ambivalence, and apprehensions of taking HIV-1 pre-exposure prophylaxis among male couples in San Francisco: a mixed methods study. PLoS One. 2012; 7(11):e50061. PMID: 23166819.
      View in: PubMed
    36. Bruno C, Saberi P. Pharmacists as providers of HIV pre-exposure prophylaxis. Int J Clin Pharm. 2012 Dec; 34(6):803-6. PMID: 23073703.
      View in: PubMed
    37. Saberi P, Caswell NH, Jamison R, Estes M, Tulsky JP. Directly observed versus self-administered antiretroviral therapies: preference of HIV-positive jailed inmates in San Francisco. J Urban Health. 2012 Oct; 89(5):794-801. PMID: 22547327.
      View in: PubMed
    38. Saberi P, Comfort M, Johnson MO. The relationship between daily organization and adherence to antiretroviral therapy: a qualitative perspective. J Acquir Immune Defic Syndr. 2012 Sep 01; 61(1):e3-6. PMID: 22918127.
      View in: PubMed
    39. Johnson MO, Sevelius JM, Dilworth SE, Saberi P, Neilands TB. Preliminary support for the construct of health care empowerment in the context of treatment for human immunodeficiency virus. Patient Prefer Adherence. 2012; 6:395-404. PMID: 22654510.
      View in: PubMed
    40. Saberi P, Dong BJ, Johnson MO, Greenblatt RM, Cocohoba JM. The impact of HIV clinical pharmacists on HIV treatment outcomes: a systematic review. Patient Prefer Adherence. 2012; 6:297-322. PMID: 22536064.
      View in: PubMed
    41. Saberi P, Johnson MO. Technology-based self-care methods of improving antiretroviral adherence: a systematic review. PLoS One. 2011; 6(11):e27533. PMID: 22140446.
      View in: PubMed
    42. Saberi P, Johnson MO, McCulloch CE, Vittinghoff E, Neilands TB. Medication adherence: tailoring the analysis to the data. AIDS Behav. 2011 Oct; 15(7):1447-53. PMID: 21833689.
      View in: PubMed
    43. Saberi P, Neilands TB, Johnson MO. Quality of sleep: associations with antiretroviral nonadherence. AIDS Patient Care STDS. 2011 Sep; 25(9):517-24. PMID: 21770763.
      View in: PubMed
    44. Bruno CB, Schapiro JM, Saberi P. An Increase in Serum Creatinine after Initiation of Fenofibrate in an HIV-Infected Individual: A Case Report and Review of the Literature. J Int Assoc Physicians AIDS Care (Chic). 2011 Jul-Aug; 10(4):219-22. PMID: 21518854.
      View in: PubMed
    45. Saberi P, Ranatunga DK, Quesenberry CP, Silverberg MJ. Clinical implications of the nelfinavir-proton pump inhibitor drug interaction in patients with human immunodeficiency virus. Pharmacotherapy. 2011 Mar; 31(3):253-61. PMID: 21361735.
      View in: PubMed
    46. Ma A, Chen DM, Chau FM, Saberi P. Improving adherence and clinical outcomes through an HIV pharmacist's interventions. AIDS Care. 2010 Oct; 22(10):1189-94. PMID: 20640958.
      View in: PubMed
    47. Saberi P, Caswell N, Amodio-Groton M, Alpert P. Pharmacy-refill measure of adherence to efavirenz can predict maintenance of HIV viral suppression. AIDS Care. 2008 Jul; 20(6):741-5. PMID: 18576177.
      View in: PubMed
    48. Saberi P, Caswell NH, Gruta CI, Tokumoto JN, Dong BJ. Immunologic benefits of enfuvirtide in patients enrolled in a drug assistance program. Ann Pharmacother. 2008 May; 42(5):621-6. PMID: 18413688.
      View in: PubMed
    49. June Riedlinger, Niamh Higgins, Parya Saberi. A Rainforest Expedition with The Student Rainforest Fund. Journal of Herbal Pharmacotherapy. 2005 Jan 1; 5(3):103-105.
      View in: Publisher Site
    Parya's Networks
    Concepts
    Derived automatically from this person's publications.
    See all (163) concept(s)
    _
    Co-Authors
    People in Profiles who have published with this person.
    See all (30) people
    _
    Similar People
    People who share similar concepts with this person.
    See all (60) people
    _
    Same Department
    Search Department
    ↑